or Try an Advanced Search...

    Technical Analysis for NTBL - Notable Labs, Ltd.

    Grade Last Price % Change Price Change
    F 1.54 29.35% 0.35
    NTBL closed up 11.21 percent on Wednesday, May 8, 2024, on 2.45 times normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical NTBL trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish 29.35%
    Pocket Pivot Bullish Swing Setup 29.35%
    Wide Bands Range Expansion 29.35%
    Upper Bollinger Band Touch Strength 29.35%
    Gapped Down Weakness 29.35%
    1,2,3 Retracement Bearish Bearish Swing Setup 43.86%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 43.86%
    Crossed Above 20 DMA Bullish 43.86%
    Pocket Pivot Bullish Swing Setup 43.86%
    Wide Bands Range Expansion 43.86%
    Older End-of-Day Signals for NTBL ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 2 hours ago
    Rose Above 50 DMA about 2 hours ago
    Rose Above Previous Day's High about 2 hours ago
    Rose Above Upper Bollinger Band about 2 hours ago
    50 DMA Resistance about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NTBL Chart by TradingView
    Basic chart:

    Profile

    Notable Labs, Ltd. Description

    Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Treatment Acute Myeloid Leukemia Orphan Drug Protein Kinase Inhibitor Myelodysplastic Syndrome Chronic Myeloid Leukemia Kinase 1 Lintuzumab

    Is NTBL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
    Apr 8 Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
    Mar 5 Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
    Dec 13 Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes
    Dec 11 Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant
    Dec 4 Notable Labs to Participate in JMP Securities Hematology and Oncology Summit
    Nov 14 Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
    Nov 9 Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML
    See more NTBL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.2
    52 Week Low 0.833
    Average Volume 84,746
    200-Day Moving Average 3.84
    50-Day Moving Average 1.35
    20-Day Moving Average 1.01
    10-Day Moving Average 0.98
    Average True Range 0.12
    RSI (14) 54.55
    ADX 30.36
    +DI 26.17
    -DI 23.57
    Chandelier Exit (Long, 3 ATRs) 1.17
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.20
    Lower Bollinger Band 0.82
    Percent B (%b) 0.98
    BandWidth 36.98
    MACD Line -0.09
    MACD Signal Line -0.13
    MACD Histogram 0.0353
    Fundamentals Value
    Market Cap 10.71 Million
    Num Shares 9 Million
    EPS -1.61
    Price-to-Earnings (P/E) Ratio -0.74
    Price-to-Sales 90.01
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.54
    Resistance 3 (R3) 1.52 1.38 1.48
    Resistance 2 (R2) 1.38 1.30 1.39 1.46
    Resistance 1 (R1) 1.29 1.24 1.34 1.31 1.44
    Pivot Point 1.15 1.15 1.18 1.16 1.15
    Support 1 (S1) 1.06 1.07 1.11 1.08 0.94
    Support 2 (S2) 0.92 1.01 0.93 0.92
    Support 3 (S3) 0.83 0.92 0.90
    Support 4 (S4) 0.85